Role of SES in childhood cancer survival disparitiesAugust 21, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Treatment guidelines for CAR T-cell therapyAugust 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Adult CCSs report financial hardshipsAugust 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
CHMP announces 2 opinions on blinatumomabJuly 31, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Global burden of hematologic malignanciesJuly 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Treatments, disease affect spermatogonia in boysJuly 25, 2018AnemiaLeukemia, Myelodysplasia, TransplantationPediatricsTransplantationAMLALLMyelodysplastic Syndrome
Team finds potential therapeutic targets for T-ALLJuly 24, 2018Leukemia, Myelodysplasia, TransplantationALL
FDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Diabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
CHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive Lymphomas
Company stops development of eryaspase in ALLJune 27, 2018Leukemia, Myelodysplasia, TransplantationALL
EC grants blinatumomab full approvalJune 21, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
Gene signature might identify patients at risk of CAR T-associated neurotoxicityJune 19, 2018Leukemia, Myelodysplasia, TransplantationALL
